Education
About Us
Working with TipRanks
Follow Us
Eli Lilly And Company (DE:LLY)
:LLY
LLY Analyst Ratings
Strong Buy
18 Buy
1 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
LLY Stock 12 Month Forecast
Average Price Target
€939.51
▲(23.49% Upside)
| Highest Price Target€1,053 | Average Price Target€939.51 | Lowest Price Target€826.79 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Citi
Reiterated
03/28/25
Bernstein
Reiterated
03/25/25
Jefferies
Reiterated
03/24/25
Leerink Partners
Reiterated
03/21/25
Berenberg Bank
Reiterated
03/21/25
Wells Fargo
Reiterated
03/10/25
Morgan Stanley
Reiterated
03/10/25
J.P. Morgan
Reiterated
02/26/25
Truist Financial
Reiterated
02/26/25
Deutsche Bank
€927.84
Buy
21.96%
Upside
Reiterated
02/26/25
Deutsche Bank reiterates Buy Rating on Eli Lilly (LLY) Amid New U.S. InvestmentDeutsche Bank analyst James Shin reiterated a Buy rating and $1,010.00 price target on Eli Lilly (NYSE: LLY) after the company said it plans to double its U.S. manufacturing investment.
BMO Capital
€927.84
Buy
21.96%
Upside
Reiterated
02/25/25
Eli Lilly & Co's Strategic Expansion and Growth Prospects Drive Buy Rating
DBS
€826.79
Buy
8.67%
Upside
Reiterated
02/17/25
Eli Lilly & Co: Promising Growth Driven by Innovative Pipeline and Market-Leading Weight-Loss Treatments
Bank of America Securities
€915.89→€918.65
Buy
20.75%
Upside
Reiterated
02/07/25
Eli Lilly & Co: Strong Buy Rating Backed by Long-Term Growth Potential in GLP-1 Obesity Market
Erste Group
―
Buy
―
Upgraded
02/05/25
Eli Lilly upgraded to Buy from Hold at Erste GroupEli Lilly upgraded to Buy from Hold at Erste Group
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Citi
Reiterated
03/28/25
Bernstein
Reiterated
03/25/25
Jefferies
Reiterated
03/24/25
Leerink Partners
Reiterated
03/21/25
Berenberg Bank
Reiterated
03/21/25
Wells Fargo
Reiterated
03/10/25
Morgan Stanley
Reiterated
03/10/25
J.P. Morgan
Reiterated
02/26/25
Truist Financial
Reiterated
02/26/25
Deutsche Bank
€927.84
Buy
21.96%
Upside
Reiterated
02/26/25
Deutsche Bank reiterates Buy Rating on Eli Lilly (LLY) Amid New U.S. InvestmentDeutsche Bank analyst James Shin reiterated a Buy rating and $1,010.00 price target on Eli Lilly (NYSE: LLY) after the company said it plans to double its U.S. manufacturing investment.
BMO Capital
€927.84
Buy
21.96%
Upside
Reiterated
02/25/25
Eli Lilly & Co's Strategic Expansion and Growth Prospects Drive Buy Rating
DBS
€826.79
Buy
8.67%
Upside
Reiterated
02/17/25
Eli Lilly & Co: Promising Growth Driven by Innovative Pipeline and Market-Leading Weight-Loss Treatments
Bank of America Securities
€915.89→€918.65
Buy
20.75%
Upside
Reiterated
02/07/25
Eli Lilly & Co: Strong Buy Rating Backed by Long-Term Growth Potential in GLP-1 Obesity Market
Erste Group
―
Buy
―
Upgraded
02/05/25
Eli Lilly upgraded to Buy from Hold at Erste GroupEli Lilly upgraded to Buy from Hold at Erste Group
LLY Analyst Recommendation Trends
Rating
Nov 24
Dec 24
Jan 25
Feb 25
Mar 25
Strong Buy
0
1
2
2
1
Buy
55
51
49
60
62
Hold
5
3
5
2
2
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
60
55
56
64
65
Each month's total comprises the sum of three months' worth of ratings.
LLY Financial Forecast
LLY Stock Forecast FAQ
What is DE:LLY’s average 12-month price target, according to analysts?
Based on analyst ratings, Eli Lilly And Company’s 12-month average price target is €939.51.
What is DE:LLY’s upside potential, based on the analysts’ average price target?
Eli Lilly And Company has 23.49% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Eli Lilly And Company a Buy, Sell or Hold?
Eli Lilly And Company has a consensus rating of Strong Buy, which is based on 18 buy ratings, 1 hold ratings and 0 sell ratings.
What is Eli Lilly And Company’s share price target?
The average share price target for Eli Lilly And Company is €939.51. This is based on 19 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €1,052.77 ,and the lowest forecast is €826.79. The average share price target represents 23.49% Increase from the current price of €760.8.
The highest analyst share price target is €1,052.77 ,and the lowest forecast is €826.79. The average share price target represents 23.49% Increase from the current price of €760.8.
What do analysts say about Eli Lilly And Company?
Eli Lilly And Company’s analyst rating consensus is a Strong Buy. This is based on the ratings of 19 Wall Streets Analysts.
How can I buy shares of Eli Lilly And Company?
To buy shares of DE:LLY, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.